✦ LIBER ✦

STAT3 Implicated in the Development of Colon Cancer: A Step Closer for Targeted Therapy?

✍ Scribed by George K.K. Lau; Dewei Ye

Book ID: 119761563
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 149 KB
Volume: 139
Category: Article
ISSN: 0016-5085
DOI: 10.1053/j.gastro.2010.05.030

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

SP-0523 THE IMPORTANCE OF RAS MUTATIONS

SP-0523 THE IMPORTANCE OF RAS MUTATIONS FOR TARGETED THERAPY IN COLON CANCER

✍ K. Haustermans; A. Debucquoy 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 77 KB

In vivo antitumor efficacy of STAT3 bloc

In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy

✍ Xi, Sichuan; Gooding, William E; Grandis, Jennifer Rubin 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 244 KB

Development and application of a method

Development and application of a method for identification of isothiocyanate-targeted molecules in colon cancer cells

✍ Noriyuki Miyoshi; Takumi Yonemochi; Susumu Tomono; Ryuuta Fukutomi; Yoshimasa Na 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 984 KB

Paclitaxel Derivatives for Targeted Ther

Paclitaxel Derivatives for Targeted Therapy of Cancer: Toward the Development of Smart Taxanes†

✍ Safavy, Ahmad; Raisch, Kevin P.; Khazaeli, M. B.; Buchsbaum, Donald J.; Bonner, 📂 Article 📅 1999 🏛 American Chemical Society 🌐 English ⚖ 120 KB

STAT3 is essential for the maintenance o

STAT3 is essential for the maintenance of neurosphere-initiating tumor cells in patients with glioblastomas: A potential for targeted therapy?

✍ Claire Villalva; Severine Martin-Lannerée; Ulrich Cortes; Fatima Dkhissi; Michel 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 762 KB

## Abstract Glioblastoma (GBM), the highest‐grade form of gliomas, is the most frequent and the most aggressive. Recently, a subpopulation of cells with stem cells characteristics, commonly named “tumor‐initiating stem cells” (TISCs) or “cancer stem cells” (CSCs) were identified in GBM. These cells

448 CHARACTERIZATION OF THE AKT-MTOR PAT

448 CHARACTERIZATION OF THE AKT-MTOR PATHWAY IN TFE3-FUSION RENAL CELL CANCERS AND IMPLICATIONS FOR TARGETED THERAPY

✍ Kauffman, Eric; Gupta, Gopal; Cecchi, Fabiola; Raffensperger, Kristen; Linehan, 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 59 KB